Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment.
Bürli RW, Doyle KJ, Dickson L, Rowland A, Matthews K, Stott AJ, Teall M, Ossola B, Russell SG, Harvey JRM, Wu Y, Narayana L, Brice NL, Carlton M, Dawson LA.
Bürli RW, et al. Among authors: harvey jrm.
ACS Med Chem Lett. 2024 Apr 5;15(5):646-652. doi: 10.1021/acsmedchemlett.4c00035. eCollection 2024 May 9.
ACS Med Chem Lett. 2024.
PMID: 38746889